Alzheimer's Disease Clinical Trials

Showing 1901-1920 of 1,974 trials

Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers

NCT00329082

To study the safety of LY2062430 in patients with mild-to-moderate Alzheimer's disease and in healthy volunteers.

Eli Lilly and Company25 participantsStarted May 2006

New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States • Indianapolis, Indiana, United States +3 more locations

COMPLETEDPhase 2

Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease

NCT00481520

The primary purpose of the study is to assess whether SAM-531, an investigational drug, is safe and well tolerated, compared with placebo (a medically inactive substance), in subjects with mild to moderate Alzheimer's disease.

Alzheimer Disease

Wyeth is now a wholly owned subsidiary of Pfizer72 participantsStarted Jun 2007

Delray Beach, Florida, United States • Hallandale, Florida, United States • St. Petersburg, Florida, United States +4 more locations

Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers

Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease

Related Searches

Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease

Pioglitazone in Alzheimer Disease

Cognitive and Emotional Impairment After Stroke

Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

A Safety Study of LY2811376 Single Doses in Healthy Subjects

Treatment Routes for Exploring Agitation

Drug Interaction Study Between AZD3480 and Warfarin

Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects

Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects

VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)

Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease

Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

Prevalence and Recognition of Geriatric Syndrome in Outpatient Clinic at Srinagarind Hospital

Effect of Activities and Exercise on Sleep in Elderly Persons With Dementia

MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology